Cargando…
Whole-genome sequencing identifies ADGRG6 enhancer mutations and FRS2 duplications as angiogenesis-related drivers in bladder cancer
Bladder cancer is one of the most common and highly vascularized cancers. To better understand its genomic structure and underlying etiology, we conduct whole-genome and targeted sequencing in urothelial bladder carcinomas (UBCs, the most common type of bladder cancer). Recurrent mutations in noncod...
Autores principales: | Wu, Song, Ou, Tong, Xing, Nianzeng, Lu, Jiang, Wan, Shengqing, Wang, Changxi, Zhang, Xi, Yang, Feiya, Huang, Yi, Cai, Zhiming |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6372626/ https://www.ncbi.nlm.nih.gov/pubmed/30755618 http://dx.doi.org/10.1038/s41467-019-08576-5 |
Ejemplares similares
-
Comparative Analysis of Differentially Mutated Genes in Non-Muscle and Muscle-Invasive Bladder Cancer in the Chinese Population by Whole Exome Sequencing
por: Wang, Fangming, et al.
Publicado: (2022) -
Detection of the
ADGRG6
hotspot mutations in urine for bladder cancer early screening by ARMS‐qPCR
por: Tan, Dan, et al.
Publicado: (2023) -
Expression of CD74 in bladder cancer and its suppression in association with cancer proliferation, invasion and angiogenesis in HT-1376 cells
por: Gai, Jun-Wei, et al.
Publicado: (2018) -
IMP3 is a biomarker for non-muscle-invasive urothelial carcinoma of the bladder associated with an aggressive phenotype
por: Yang, Feiya, et al.
Publicado: (2019) -
LMTK3 promotes tumorigenesis in bladder cancer via the ERK/MAPK pathway
por: Jiang, Tao, et al.
Publicado: (2020)